Gut microbiota composition is predictive of CAR-T cells response and its modulation enhances CAR-T cells activity

被引：0
|
作者：
Marcos-Kovandzic, L. [1 ]
Rengassamy, J. [2 ]
Ferrere, G. [3 ]
Srikanthan, J. [4 ]
Durand, S. [5 ]
Derosa, L. [6 ]
Bigenwald, C. [7 ]
Zitvogel, L. [7 ]
机构：
[1] Gustave Roussy, Unite 1015, Villejuif, France
[2] Inst Gustave Roussy, Dept Hematol, Villejuif, France
[3] Gustave Roussy Canc Campus, Everimmune, Villejuif, France
[4] Gustave Roussy, Dept Hematol, Villejuif, France
[5] Gustave Roussy, INSERM U1030, Villejuif, France
[6] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
[7] Inst Gustave Roussy, U1015, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
基金：
欧盟地平线“2020”;
关键词：
D O I：
10.1016/j.annonc.2024.08.855
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
804MO
引用
收藏
页码：S598 / S598
页数：1
相关论文
共 50 条
  • [21] A bacterial assist for CAR-T cells
    Kathryn Aschheim
    Nature Biotechnology, 2023, 41 : 1521 - 1521
  • [22] CAR-T cells: the Chinese experience
    Wang, Linqin
    Tan Su Yin, Elaine
    Zhao, Houli
    Ni, Fang
    Hu, Yongxian
    Huang, He
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (11) : 1293 - 1308
  • [23] A bacterial assist for CAR-T cells
    Aschheim, Kathryn
    NATURE BIOTECHNOLOGY, 2023, 41 (11) : 1521 - 1521
  • [24] CAR-T Cells: Future Perspectives
    Charrot, Sarah
    Hallam, Simon
    HEMASPHERE, 2019, 3 (02):
  • [25] Depletion of Tregs from CD4+ CAR-T cells enhances the tumoricidal effect of CD8+ CAR-T cells in anti-CD19 CAR-T therapy
    Sun, Yunyan
    Liu, Jinyan
    Zhan, Dong
    Wei, Jia
    Li, XianShi
    Zhang, Rui
    Duan, Ci
    Zhang, Disi
    Tang, Xiaorong
    Lin, Tuo
    Li, Limei
    Lai, Xun
    FEBS JOURNAL, 2024,
  • [26] Lenalidomide Enhances CAR-T Cell Activity Against Solid Tumor Cells
    Wang, Zhixiong
    Zhou, Guomin
    Risu, Na
    Fu, Jiayu
    Zou, Yan
    Tang, Jiaxing
    Li, Long
    Liu, Hui
    Liu, Qian
    Zhu, Xuekai
    CELL TRANSPLANTATION, 2020, 29
  • [27] Implications of TET2 in CAR-T Cell Activity and Target Response to CAR-T Cell Therapy: Lessons Learned from T Cells
    Pasca, Sergiu
    Jurj, Ancuta
    Constantinescu, Catalin
    Zdrenghea, Mihnea
    Tomuleasa, Ciprian
    CRITICAL REVIEWS IN IMMUNOLOGY, 2021, 41 (01) : 13 - 21
  • [28] Ruxolitinib reduces severe CRS response by suspending CAR-T cell function instead of damaging CAR-T cells
    Xu, Nan
    Yang, Xiao-Fei
    Xue, Sheng-Li
    Tan, Jing-Wen
    Li, Ming-Hao
    Ye, Jing
    Lou, Xiao-Yan
    Yu, Zhou
    Kang, Li-Qing
    Yan, Zhi-Qiang
    Yu, Lei
    Chen, Su-Ning
    Wang, Yi-Ting
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 595 : 54 - 61
  • [29] Gut microbiome and CAR-T therapy
    Abid, Muhammad Bilal
    Shah, Nirav N.
    Maatman, Theresa C.
    Hari, Parameswaran N.
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2019, 8 (01)
  • [30] Gut microbiome and CAR-T therapy
    Muhammad Bilal Abid
    Nirav N. Shah
    Theresa C. Maatman
    Parameswaran N. Hari
    Experimental Hematology & Oncology, 8
12345